This company seems to have been delisted
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Albireo Pharma
ALBO
40,67 €
Share price
0.00%
Change (1 day)
119.76%
Change (1 year)
Categories
Albireo Pharma (ALBO) - Cash on Hand
Cash on Hand as of September 2022 : €0.20 Billion
According to Albireo Pharma's latest financial reports the company has €0.20 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Albireo Pharma - Cash on Hand chart (from 2005 to 2022)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2021-12-31 | €0.21 B | 7.24% |
| 2020-12-31 | €0.20 B | 73.58% |
| 2019-12-31 | €0.11 B | -17.84% |
| 2018-12-31 | €0.14 B | 222.91% |
| 2017-12-31 | €44.36 M | 55.91% |
| 2016-12-31 | €28.45 M | |
| 2016-09-30 | €25.56 M | -29.55% |
| 2015-09-30 | €36.28 M | 87.29% |
| 2014-09-30 | €19.37 M | -34.27% |
| 2013-09-30 | €29.47 M | -2.94% |
| 2012-09-30 | €30.37 M | 6.61% |
| 2011-09-30 | €28.48 M | 34.22% |
| 2010-09-30 | €21.22 M | -43.08% |
| 2009-09-30 | €37.28 M | -41.79% |
| 2008-09-30 | €64.04 M | 13.21% |
| 2007-09-30 | €56.57 M | 308.38% |
| 2006-09-30 | €13.85 M | 4427.95% |
| 2005-09-30 | €0.3 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | €0.23 B | 15.05% | 🇺🇸 USA |